SNORD62A: A Potential Drug Target and Biomarker (G26786)

Target Name: SNORD62A

NCBI ID: G26786

SNORD62A

Other Name(s): RNU62 | Small nucleolar RNA, C/D box 62A | small nucleolar RNA, C/D box 62A | U62A | U62

SNORD62A: A Potential Drug Target and Biomarker

SNORD62A, short for small nucleolar RNA-domain protein 62A, is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in the nucleus. It is a key player in the process of transcription, which is the process by which the information in DNA is translated into RNA. SNORD62A is a small RNA molecule that contains only 19 amino acid residues and has been shown to play a critical role in the regulation of gene expression in various organisms, including humans.

Recent studies have identified SNORD62A as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This is due to its unique structure and the various functions that it has been shown to play in the cell.

One of the key functions of SNORD62A is its role in the regulation of microRNA (miRNA) levels. miRNA are small non-coding RNAs that play a critical role in the regulation of gene expression by binding to specific mRNAs and causing them to be either translated into protein or degraded. SNORD62A has been shown to interact with miRNA-21, a well-known regulator of gene expression, and it is thought to play a role in the regulation of miRNA levels.

Another function of SNORD62A is its role in the regulation of gene expression in the nucleus. SNORD62A has been shown to interact with various nuclear proteins, including histone modification enzymes and transcription factors. This suggests that it may play a role in the regulation of gene expression by binding to these proteins and modulating their activity.

In addition to its role in the regulation of miRNA and gene expression, SNORD62A has also been shown to play a critical role in the regulation of cellular processes such as cell division, apoptosis, and inflammation. It is involved in the regulation of the expression of genes that are involved in cell division, apoptosis, and inflammation, and it is thought to play a key role in the regulation of these processes.

Given its unique structure and the various functions that it has been shown to play, SNORD62A is a promising drug target and biomarker for a variety of diseases. Studies have shown that inhibiting the activity of SNORD62A has the potential to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In conclusion, SNORD62A is a small RNA molecule that plays a critical role in the regulation of gene expression in the nucleus. Its unique structure and various functions make it a promising drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of SNORD62A in the regulation of gene expression and the development of effective treatments for various diseases.

Protein Name: Small Nucleolar RNA, C/D Box 62A

The "SNORD62A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD62A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets